Belmont Medical Technologies Competitors and Similar CompaniesClear all

Belmont Medical Technologies's competitors and similar companies include Midmark, Richard Wolf, Southern Prosthetic Supplies and Zhejiang Gongdong Medical Technology.

	Belmont Medical Technologies Belmont Medical Technologies is a company that manufactures medical devices.	Midmark Midmark is a company that manufactures and supplies medical, dental, and veterinary equipment.	Richard Wolf Richard Wolf is a supplier of products and solutions for endoscopy and extracorporeal shock wave treatment.	Southern Prosthetic Supplies Southern Prosthetic Supplies (SPS) is a company that distributes orthotic and prosthetic products.	Zhejiang Gongdong Medical Technology Zhejiang Gongdong Medical Technology is a manufacturer and supplier of medical devices and supplies.
Founding Date	Founding Date 1980	Founding Date 1915	Founding Date 1906	Founding Date 1951	Founding Date 1985
Type	Type Private	Type Private	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare medical devices	Tags Healthcare dental ecommerce medical devices veterinary	Tags Healthcare medical devices	Tags Retail distribution medical devices	Tags Healthcare medical devices
Locations	Locations Billerica, US HQ Wokingham, GB	Locations Versailles, US HQ Brisbane City, AU Melbourne, AU Perth, AU Sydney, AU Bruxelles, BE São Paulo, BR see more	Locations Knittlingen, DE HQ Wien, AT Gent, BE Sao Paulo, BR Beijing, CN Shanghai, CN Reims, FR see more	Locations Alpharetta, US HQ Fresno, US	Locations Taizhou, CN HQ Riverside, US
Employees	Employees 1851% increase	Employees 2,200	Employees 1,800	Employees 1981% increase	Employees 1,693
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $717m (FY, 2022)	Revenue (est.) €249.9m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) ¥1.1b (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €70.1m (FY, 2021)	Cost of goods N/A	Cost of goods ¥749.5m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit €179.7m (FY, 2021)	Gross profit N/A	Gross profit ¥352.8m (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income €4.1m (FY, 2021)	Net income N/A	Net income ¥171.5m (FY, 2024)